HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins
about
Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatinDo the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhageStatin therapy is not associated with improved vascular access outcomes.Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.Statins as first-line therapy for acute coronary syndrome?Statins in the first-line therapy of acute coronary syndrome - similar to aspirin?Effect of orally administered simvastatin on prevention of postoperative adhesion in rats.Statins in sepsis.Topical simvastatin enhances tissue regeneration in full-thickness skin wounds in rat modelsRisk of arteriovenous fistula failure associated with hypnotic use in hemodialysis patients: a nested case-control study.Atorvastatin affects several angiogenic mediators in human endothelial cells.Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta.Protective effects of statins involving both eNOS and tPA in focal cerebral ischemiaStatins suppress glucose-induced plasminogen activator inhibitor-1 expression by regulating RhoA and nuclear factor-κB activities in cardiac microvascular endothelial cells.Concomitant administration of different doses of simvastatin with ivabradine influence on PAI-1 and heart rate in normo- and hypercholesterolaemic rats.Effect of statins on experimental postoperative adhesion: a systematic review and meta-analysisThe inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways
P2860
Q24646870-4A57ADBC-A17C-45A9-8A32-B4B7CACCC8E0Q24804153-3AB1192D-289A-47DC-AEE3-76A943AFC952Q33836890-C2268451-CE5B-4BCE-ADBA-B1CBE0AF0D59Q34075472-D92CD1D3-AC79-437E-B9C1-A191A5B2D688Q34986710-0C715888-9973-43F3-89F3-10AE835DEFE9Q36768488-7D27F731-615B-4894-AEDB-CC1C2F56DEC0Q37276466-B748DF9B-41E8-4B28-9145-F159EEC3D22CQ37597453-E2A98BF2-EB8F-4207-A922-BC0629A36E8AQ37867264-4F6124E7-1169-4D16-99B1-006975917180Q38729137-2C38FCF2-89CB-4051-8CF9-8BAECF394109Q40073960-27A1EE9A-BF94-44C0-ACF5-B4374FFB1958Q41833012-4C109030-D85F-4150-AF2C-5F8EB2883604Q42389664-7D8627FF-A249-4D66-8513-AE8DCBE07136Q42552752-FB05F4FD-953D-4819-AFC1-955BC17A8FDAQ46210874-E9483567-ECD2-4EFB-9D09-FB926F6B12BEQ55687041-A073C9C6-213D-46FF-AFE0-EA7F700955FCQ57041830-B546C194-377A-4E0E-AB99-E64723CDBEB3Q58071384-08984BC3-BB6C-470F-B7D5-BB79BD5C55D8
P2860
HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HMG CoA reductase inhibitors a ...... study using different statins
@ast
HMG CoA reductase inhibitors a ...... study using different statins
@en
HMG CoA reductase inhibitors a ...... study using different statins
@nl
type
label
HMG CoA reductase inhibitors a ...... study using different statins
@ast
HMG CoA reductase inhibitors a ...... study using different statins
@en
HMG CoA reductase inhibitors a ...... study using different statins
@nl
prefLabel
HMG CoA reductase inhibitors a ...... study using different statins
@ast
HMG CoA reductase inhibitors a ...... study using different statins
@en
HMG CoA reductase inhibitors a ...... study using different statins
@nl
P2093
P2860
P356
P1476
HMG CoA reductase inhibitors a ...... study using different statins
@en
P2093
Christoph Kaun
Franz Wiesbauer
Gerald Maurer
Gerlinde Zorn
Kurt Huber
P2860
P304
P356
10.1038/SJ.BJP.0704454
P407
P50
P577
2002-01-01T00:00:00Z